Tianjin TEDA Biomedical Engineering Company Limited (8189.HK) HKSE

0.39

+0.005(+1.32%)

Updated at November 14 02:11PM

Currency In HKD

Valuation

Market Cap542.29M
Enterprise Value676.81M
P/E Ratio-83.81
PEG Ratio44.42
Price/Sales Ratio2.26
Price/Book Ratio7.36
Enterprise/Revenue2.44
Enterprise/EBITDA-279.66

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.03
Operating Margin-0.03

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.14

Income Statement

Revenue385.48M
Revenue/Share0.16
Gross Profit16.97M
EBITDA-20.19M
Net Income-27.8M
Diluted EPS-0.02

Balance Sheet

Total Cash186.13M
Total Cash/Share0.09
Total Debt112.58M
Total Debt/Equity1.17
Current Ratio1.1
Book Value Per Share0.05

Price History

52-Week Change75
52-Week High0.65
52-Week Low0.2
Moving Average 50 Days0.41
Moving Average 200 Days0.44

Statistics

Average Volume1.3M
Shares Outstanding2.14B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A